MSMartín Arturo Silva-Ramírez

Martín Arturo Silva-Ramírez

*This is an algorithmically generated author record based on publicly available information.

Martín Arturo Silva-Ramírez has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Synthetic EEG Signal Generator of Morphologies Associated with Epileptogenic Events

    by José-Emmanuel Vazquez-Galán, Blanca Tovar-Corona, Laura-Ivoone Garay-Jiménez, Martín-Arturo Silva-Ramírez

    Electroencephalography is crucial for understanding brain signals. This work presents a methodology for synthetic EEG signal generation to simulate frequency bands, incorporate noise, and emulate specific phenomena. A Python-based tool allows controlled signal generation and export in various formats, and features a visualizer for analyzing user-uploaded signals in TXT, CSV, or EDF formats. EEGLAB evaluation confirms the accuracy and consistency of the generated signals. The tool supports research, diagnosis, and data analysis models requiring large datasets, particularly in neurological diseases like epilepsy. Pending web hosting, the tool will enhance accessibility and usability for broader applications.


  • Open Access

    PEDIATRIC GUILLAIN-BARRÉ SYNDROME IN MÉXICO CLINICAL FEATURES BEFORE AND DURING SARS-COV-2 PANDEMIC

    by Fabiola Marycruz De la Fuente-Silva, Juan Antonio De la Fuente-Pineda, Martín Arturo Silva-Ramírez, Sofía Lucila Rodríguez-Rivera, Ricardo Iván Montaño-González, Paula Ramírez-Palacios

    Introduction: Guillain-Barré Syndrome is the most common cause of acute flaccid paralysis in childhood. It is a post infectious disease immune-mediated with a rapidly progressive course, usually without relapse. The main features are progressive weakness of more than one limb, areflexia or hyporeflexia, which gets progressively worst over days-to-weeks, to potentially life-threatening severity requiring mechanical ventilation. Objective: We aimed to describe the clinical features of pediatric Guillain-Barré Syndrome in México before and during SARS-CoV-2 pandemic. Methods: We performed an ambispective, observational, cross-sectional study in a Mexican reference hospital from January 2013 to December 2021. Data were obtained through records: demographic, clinical, laboratories, neurophysiological variants and treatment. Results: Here we show that of the 96 patients, 55 were males with mean age of 9 years, 72% had history of infection; progressive weakness was present in 97%, areflexia/hyporeflexia 97%, progression of symptoms 99%, mean cells of 9/mm3 and mean proteins 88 mg/dL. Admission to Pediatric Intensive Care Unit was 20%. Acute Motor Axonal Neuropathy was the most frequent subtype. Nineteen patients required mechanical ventilation. Immunoglobulin was administered in 88%. Most frequent Disability Score at discharge was bedridden/wheelchair-bound. During 2020-2021 we found two SARS-CoV-2 cases and one associated with BNT162b2 vaccine. Conclusions: Our results demonstrate that clinical features of pediatric Guillain-Barré Syndrome are similar before and during SARS-CoV-2 pandemic, nevertheless the number of cases associated with SARS-CoV-2 infection did not find increase.

  • Open Access

    PEDIATRIC GUILLAIN-BARRÉ SYNDROME IN MÉXICO CLINICAL FEATURES BEFORE AND DURING SARS-COV-2 PANDEMIC

    by Fabiola Marycruz De la Fuente-Silva, Juan Antonio De la Fuente-Pineda, Martín Arturo Silva-Ramírez, Sofía Lucila Rodríguez-Rivera, Ricardo Iván Montaño-González, Paula Ramírez-Palacios

    Introduction: Guillain-Barré Syndrome is the most common cause of acute flaccid paralysis in childhood. It is a post infectious disease immune-mediated with a rapidly progressive course, usually without relapse. The main features are progressive weakness of more than one limb, areflexia or hyporeflexia, which gets progressively worst over days-to-weeks, to potentially life-threatening severity requiring mechanical ventilation. Objective: We aimed to describe the clinical features of pediatric Guillain-Barré Syndrome in México before and during SARS-CoV-2 pandemic. Methods: We performed an ambispective, observational, cross-sectional study in a Mexican reference hospital from January 2013 to December 2021. Data were obtained through records: demographic, clinical, laboratories, neurophysiological variants and treatment. Results: Here we show that of the 96 patients, 55 were males with mean age of 9 years, 72% had history of infection; progressive weakness was present in 97%, areflexia/hyporeflexia 97%, progression of symptoms 99%, mean cells of 9/mm3 and mean proteins 88 mg/dL. Admission to Pediatric Intensive Care Unit was 20%. Acute Motor Axonal Neuropathy was the most frequent subtype. Nineteen patients required mechanical ventilation. Immunoglobulin was administered in 88%. Most frequent Disability Score at discharge was bedridden/wheelchair-bound. During 2020-2021 we found two SARS-CoV-2 cases and one associated with BNT162b2 vaccine. Conclusions: Our results demonstrate that clinical features of pediatric Guillain-Barré Syndrome are similar before and during SARS-CoV-2 pandemic, nevertheless the number of cases associated with SARS-CoV-2 infection did not find increase.